XML 23 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE 7 COMMON STOCK WARRANTS AND OPTIONS (Detail) (USD $)
9 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Stock options issued August 26, 2009 [Member]
Dec. 31, 2009
Stock options issued August 26, 2009 [Member]
Dec. 31, 2011
Stock options issued July 2010 [Member]
Dec. 31, 2010
Stock options issued July 2010 [Member]
Sep. 30, 2012
Stock Options Issued July 2012, Net of Cancelled Options December 2011 [Member]
Sep. 30, 2012
Options granted September 2010 [Member]
Dec. 31, 2010
Options granted September 2010 [Member]
Sep. 30, 2011
Options granted March 2011 [Member]
Sep. 30, 2011
Options granted March 2011 [Member]
Dec. 31, 2011
Options granted March 2011 [Member]
Sep. 30, 2011
Options granted for web and press support services, March 2011 [Member]
Sep. 30, 2011
Options granted for web and press support services, March 2011 [Member]
Dec. 31, 2011
Options granted for web and press support services, March 2011 [Member]
Sep. 30, 2012
2012 Equity Incentive Award Plan [Member]
Sep. 30, 2012
Options granted to directors, February 2012 [Member]
Sep. 30, 2012
Options granted to officers, consultants and employees, February 2012 [Member]
Sep. 30, 2012
Options granted February 2012 [Member]
Sep. 30, 2012
Options issued for distribution related services, May 2012 [Member]
Sep. 30, 2012
Options granted for medical consulting support services, May 2012 [Member]
Sep. 30, 2012
Options granted for purchase of restricted stock [Member]
Dec. 31, 2011
Options granted March 2011 [Member]
Share-based Goods and Nonemployee Services Transaction, Securities Issued       1,500,000                                      
Option exercise price (in Dollars per share)       $ 0.10                         $ 0.23 $ 0.23       $ 0.05  
Stock option, term       5 years 5 years       5 years     5 years     5 years         5 years 5 years    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights       (i) 500,000 of the options vested immediately on the date of grant, (ii) 500,000 options will vest on the date certified by the Company as the date the Company's hospital disinfection program completes its beta-testing, and (iii) the remaining 500,000 options will vest on the date certified by the Company as the date that the Company's process has been commercialized and a minimum of 50 units or devices have been sold to third parties by the Company. did not vest until the Company has achieved commercial sales       do not vest until the Company has achieved commercialization and sales of the AsepticSure product                     do not vest until completion of specific milestones services already performed (vested immediately on the grant date) and to be performed in the future, which do not vest until completion of certain milestones    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in Shares)     500,000                                        
Allocated Share-based Compensation Expense     $ 48,699       $ 659,822 $ 65,067   $ 6,380 $ 13,731 $ 6,311 $ 4,254 $ 9,155 $ 4,206       $ 1,057,600 $ 0 $ 100,138    
Stock options, non-vested (in Shares)     500,000                                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)           3,500,000 3,250,000   250,000     150,000     100,000   1,000,000 1,050,000   1,000,000 1,000,000 2,500,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in Shares)         250,000     250,000                              
Stock option, exercise price (in Dollars per share)         $ 0.20                   $ 0.14         $ 0.17 $ 0.17    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)                 $ 0.275     $ 0.14                      
Stock options, fair value                             13,361         153,997 149,460   20,042
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)                               10,000,000              
Number of directors issued shares                                 4            
Stock option expense, to be recognized                                         49,322    
Number of Investors Granted Options                                           3  
Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition $ 1,931,325 $ 22,886